Skip to main content

Singhal Priya's Form 4 filing

Biogen Inc. (BIIB) · filed Feb 21, 2024

Accession no.
0001127602-24-006212
Filed
Feb 21, 2024
Trade date
Feb 16, 2024
Filing delay
5 days
Rule 10b5-1 plan
Checked

This filing lists 5 non-derivative transactions and 3 derivative transactions. Open-market sales total $23.9K. It was filed 5 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Singhal PriyaCIK 0001769608Officer (Head of Development)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 16, 2024Common StockMOption exerciseAcquired+819$0.00$05,335.09Direct
Feb 16, 2024Common StockFTax withholdingDisposed−295$219.08−$64,628.65,040.09Direct
Feb 16, 2024Common StockMOption exerciseAcquired+389$0.00$05,429.09Direct
Feb 16, 2024Common StockFTax withholdingDisposed−173$219.08−$37,900.845,256.09Direct
Feb 16, 2024Common StockSSaleDisposed−108$221.49−$23,920.925,148.09Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Feb 16, 2024Common StockMOption exerciseDisposed−819$0.00$00Direct
Feb 16, 2024Common StockMOption exerciseDisposed−389$0.00$0485Direct
Feb 16, 2024Common StockJOtherDisposed−485$0.00$00Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)